Researchers from the Medical University of Vienna has developed an effective vaccine against chlamydia, writes Xinhua. It managed to test on laboratory mice. According to statistics, every year in contact with chlamydia take 100 million people, chlamydia is the most common sexually transmitted.
Almost half of those infected do not notice symptoms. The appointment of conventional antibiotics for chlamydia does not make sense, and for the treatment of chronic infections may require several months.
Scientists have used nanotechnology, delivering a vaccine against chlamydia to mucous cells of the nasal cavity. This formed two waves of the immune response that has shaped the immunity against chlamydia.